I think the healthcare industry is one of the best ones to be in. It has defensive earnings because people don’t choose to get sick around economic cycles and are willing to pay what it takes to remain alive and well. Healthcare also has an exciting growth future with how much the Australian population is going to age over the next two decades. Here are three of my favourite shares to take advantage of the industry: Japara Healthcare Ltd (ASX: JHC) Japara is one of Australia’s largest aged care providers. I believe it’s an exciting opportunity because sadly at…
To keep reading, enter your email address or login below.
I think the healthcare industry is one of the best ones to be in.
It has defensive earnings because people don’t choose to get sick around economic cycles and are willing to pay what it takes to remain alive and well.
Healthcare also has an exciting growth future with how much the Australian population is going to age over the next two decades.
Here are three of my favourite shares to take advantage of the industry:
Japara Healthcare Ltd (ASX: JHC)
Japara is one of Australia’s largest aged care providers.
I believe it’s an exciting opportunity because sadly at some point the elderly can no longer function in their own home and need help in some way. A good portion of these will probably end up in an aged care facility like Japara’s.
Japara alone expect to add at least 1,000 net new beds over the next few years, which should be a sizeable boost to revenue.
Japara is currently trading at 18x FY17’s earnings with a grossed-up dividend yield of 7.96%.
NIB Holdings Limited (ASX: NHF)
NIB is one of the biggest private health insurers in Australia.
The business has cleverly linked with businesses like Qantas Airways Limited (ASX: QAN) to grow its number of policyholders. It has also recently announced that it will acquire GU Health.
I think NIB will continue to grow at a faster pace compared to the rest of the health insurance sector and peers like Medibank Private Ltd (ASX: MPL).
NIB is currently trading at 24x FY18’s estimated earnings with a grossed-up dividend yield of 4.27%.
Healthscope Ltd (ASX: HSO)
Healthscope is Australia’s second largest private hospital operator.
The number of patients who will need a hospital visit in the coming years is expected to heavily increase with the number of over-65s predicted to grow by 75% over the next two decades.
I like that Healthscope is actively adding to its capacity by increasing its number of hospital beds and operating theatres across the network.
Healthscope’s share price appears to have recovered from the worst of the bad news about its medical centres and slowing growth. Hopefully management can grow the earnings per share and dividend at a good pace from now on.
Healthscope is trading at 20x FY18’s estimated earnings with an unfranked dividend yield of 3.54%.
I’m a fan of all three businesses, which is why I own shares in two of them.
At the moment I think Healthscope will probably provide the best total shareholder return over the next two to three years once the Northern Beaches Hospital is complete as it should be a big boost to earnings.
If healthcare isn’t for you, bit you want good growth options, then you should try out these hot stocks.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor Tristan Harrison owns shares of HEALTHSCPE DEF SET and JAPARA DEF SET. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.